Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study

Keyphrases

• Beta-blockers 100%
• Retrospective Cohort Study 100%
• Chronic Obstructive Pulmonary Disease 100%
• All-cause Mortality 40%
• Hospital Admission 30%
• Scotland 20%
• Tayside 20%
• Treatment Step 20%
• Long-acting beta-agonists 20%
• Antimuscarinics 20%
• Corticosteroid Use 20%
• Oral Corticosteroids 20%
• Acute Exacerbation of COPD (AECOPD) 20%
• Scottish 10%
• Adverse Effects 10%
• Respiratory Disease 10%
• Cardiovascular Disease 10%
• Adjusted Hazard Ratio 10%
• Lung Function 10%
• Hazard Ratio 10%
• Inhaled Corticosteroids 10%
• Pulmonary Function 10%
• Age at Diagnosis 10%
• Short-acting 10%
• Acute Admission 10%
• Prescription Records 10%
• Chronic Obstructive Pulmonary Disease Patient 10%
• TARDIS 10%
• Inhaled Therapy 10%
• Cardiac Drugs 10%
• Cardioselective 10%
• Step Therapy 10%
• Disease-specific Database 10%
• Short-acting beta-agonist 10%
• Register Office 10%
• Community Pharmacy 10%
• Cox Proportional Hazards Regression 10%
• Long-acting Antimuscarinic Agents 10%
• Death Registration 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Cohort Study 100%
• Chronic Obstructive Lung Disease 100%
• Beta Adrenergic Receptor Blocking Agent 100%
• All Cause Mortality 40%
• Beta Adrenergic Receptor Stimulating Agent 30%
• Disease 10%
• Cardiovascular Disease 10%
• Disease Exacerbation 10%
• Adverse Event 10%
• Respiratory Tract Disease 10%
• Hospital Mortality 10%
• Cardiac Agent 10%
• Community Pharmacy 10%